Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2).

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2005-06-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2005.03.113PMID 15869877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.

  2004cited by this paper
• Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

  2004cited by this paper
• Recent advances in selective opioid receptor agonists and antagonists

  2004cited by this paper
• Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

  2004cited by this paper
• Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations

  2004cited by this paper
• Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A

  2003cited by this paper
• Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum.

  2003cited by this paper
• Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats

  2003cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Antidepressant effects of the herb Salvia divinorum: a case report.

  2001cited by this paper
• Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

  2001cited by this paper
• Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.

  2001cited by this paper
• Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.

  1997cited by this paper
• Activation of the Cloned Human Kappa Opioid Receptor by Agonists Enhances [35S]GTPγS Binding to Membranes: Determination of Potencies and Efficacies of Ligands

  1997cited by this paper
• Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

  1994cited by this paper
• The absolute stereochemistry of salvinorins

  1990cited by this paper
• Carbamates : A method of synthesis and some syntehtic applications

  1986cited by this paper
• Psychotomimesis mediated by kappa opiate receptors

  1986cited by this paper
• Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

  1984cited by this paper

• Opioid receptors in GtoPdb v.2025.1

  2025cites this paper
• Opioid receptors in GtoPdb v.2025.3

  2025cites this paper
• Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor.

  2023cites this paper
• Pharmacologic hyperreactivity of kappa opioid receptors in periaqueductal gray matter during alcohol withdrawal syndrome in rats

  2023influential citation
• Opioid receptors in GtoPdb v.2023.1 Opioid receptors in GtoPdb v.2023.1

  2023cites this paper
• From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design

  2023cites this paper
• Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor

  2023cites this paper
• A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

  2021influential citation
• Natural products for the treatment of pain: chemistry and pharmacology of salvinorin A, mitragynine and collybolide.

  2020cites this paper
• Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Exploring the side effect profile of 16-Ethynyl Salvinorin A

  2019cites this paper
• A review of salvinorin analogs and their kappa-opioid receptor activity.

  2018cites this paper
• Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents

  2018cites this paper
• The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects

  2017cites this paper
• An immunochromatographic assay for rapid etection of salvinorin A

  2017cites this paper
• Enzyme Immunoassay for Salvinorin A (a Main Component in Salvia divinorum)

  2016cites this paper
• Clerodane diterpenes: sources, structures, and biological activities.

  2016cites this paper
• Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists.

  2015cites this paper
• Development of an enzyme immunoassay using a monoclonal antibody against the psychoactive diterpenoid salvinorin A.

  2013cites this paper
• The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• [The estimation method of compounds opiate activity based on universal three-dimensional model of the nonselective opiate pharmacophore].

  2012cites this paper
• Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.

  2012cites this paper
• Method for estimating a compound’s opiate activity based on a versatile three-dimensional model of nonselective opiate pharmacophore

  2012cites this paper
• Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions.

  2012cites this paper
• Addressing the Interactions between Opioid Ligands and Their Receptors

  2012cites this paper
• Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands

  2012cites this paper
• Role of saturability of noncovalent interactions in the analysis of the three-dimensional structure—opioid activity relationship

  2012cites this paper
• Synthesis of neoclerodane diterpenes and their pharmacological effects.

  2011influential citation
• Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A.

  2011cites this paper
• Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter

  2011cites this paper
• Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.

  2011cites this paper
• Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A

  2011influential citation
• Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods

  2011cites this paper
• Behavioural Pharmacology of Novel Kappa Opioid Compounds

  2011cites this paper
• Preparation of neoclerodane diterpenes as probes for the opioid receptor system

  2010cites this paper
• CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.

  2010cites this paper
• Medicinal Chemistry of Kappa Opioid Receptor Antagonists

  2009cites this paper
• Salvinorin A: Fragment Synthesis and Modeling Studies

  2009cites this paper
• Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.

  2009cites this paper
• Kappa-opioid ligands in the study and treatment of mood disorders.

  2009cites this paper
• Synthetic studies on neoclerodane diterpenes from Salvia splendens: oxidative modifications of ring A.

  2009cites this paper
• Chemical methods for the synthesis and modification of neoclerodane diterpenes.

  2009cites this paper
• Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.

  2009cites this paper
• Synthesis of deacetyl-1,10-didehydrosalvinorin G.

  2008cites this paper
• Salvinorin A analogs as probes in opioid pharmacology.

  2008cites this paper
• Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of Opioid Receptor affinity.

  2008cites this paper
• N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective κ-Opioid Receptor Agonist with Oral Efficacy

  2008influential citation
• 2-Methoxymethyl-Salvinorin B Is a Potent κ Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin A

  2008cites this paper
• Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers.

  2008cites this paper
• Investigation of the interaction between the atypical agonist c[YpwFG] and MOR

  2008cites this paper
• 8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

  2007cites this paper
• Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology

  2007cites this paper
• Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase*

  2007cites this paper
• Revised structure of deacetyl-1,10-didehydrosalvinorin G.

  2007cites this paper
• Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction.

  2007cites this paper
• Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.

  2007cites this paper
• Isolation and Chemical Modification of Clerodane Diterpenoids from Salvia Species as Potential Agonists at the κ‐Opioid Receptor

  2007cites this paper
• N-methylacetamide analogue of salvinorin A: a highly potent and selective kappa opioid receptor agonist with oral efficacy

  2007influential citation
• N -Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective (cid:1) -Opioid Receptor Agonist with Oral Efficacy □ S

  2007influential citation
• Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.

  2007cites this paper
• Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.

  2006cites this paper
• Clerodane diterpenoids from Salvia splendens.

  2006cites this paper
• A unique binding epitope for salvinorin A, a non‐nitrogenous kappa opioid receptor agonist

  2006cites this paper
• Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.

  2006cites this paper
• Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

  2006cites this paper
• Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.

  2006cites this paper
• Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

  2006cites this paper
• A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist

  2006cites this paper
• PCR and PCR-RFLP of the 5S-rRNA-NTS region and salvinorin A analyses for the rapid and unequivocal determination of Salvia divinorum.

  2006cites this paper
• Salvinorin A: from natural product to human therapeutics.

  2006cites this paper
• Synthesis of salvinorin A analogues as opioid receptor probes.

  2006cites this paper
• The chemistry of Salvia divinorum

  2006cites this paper
• Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.

  2005cites this paper
• Autoxidation of salvinorin A under basic conditions.

  2005cites this paper
• Psychopharmacology of the hallucinogenic sage Salvia divinorum.

  2005cites this paper
• Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.

  2005cites this paper